CDP-855

N/A

Report date: 2023/02/18 16:53:05

Base Information

Drug NameCDP-855
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionImmunosuppressants
TargetsNot applicable
Therapy Area/IndicationsRejection of organ transplantationLupus Erythematosus, SystemicMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCelltech R&D Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCelltech R&D Ltd
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationLupus Erythematosus, SystemicMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A